Thrombophlebitis of the Superficial Veins

Key points
- Superficial thrombophlebitis may occur spontaneously in patients with varicose veins, in pregnant or postpartum women, or in patients with thromboangiitis obliterans or Behcet's disease.
- The patient usually experiences a dull pain in the region of the involved vein.
- The linear rather than circular nature of the lesion and the distribution along the course of a superficial vein help to differentiate superficial phlebitis from cellulitis, erythema nodosum, erythema induratum, panniculitis, and fibrositis.
- The primary treatment of superficial venous thrombophlebitis is the administration of nonsteroidal anti-inflammatory drugs, local heat, and elevation.
Introduction
Essentials of Diagnosis
- Induration, redness, and tenderness along a superficial vein.
- Often a history of recent intravenous line or trauma. No significant swelling of the extremity.
General Considerations
Superficial thrombophlebitis may occur spontaneously in patients with varicose veins, in pregnant or postpartum women, or in patients with thromboangiitis obliterans or Behcet's disease. It can also occur after trauma, such as a blow to the leg, or after intravenous infusion. A migratory thrombophlebitis may be a manifestation of abdominal cancer such as carcinoma of the pancreas (Trousseau's syndrome).
The long saphenous vein and its tributaries are most often involved. Superficial thrombophlebitis is associated with occult DVT in about 20% of cases. Pulmonary emboli are rare unless extension into the deep venous system occurs.
Clinical Findings
The patient usually experiences a dull pain in the region of the involved vein. Induration, redness, and tenderness correspond to dilated, thrombosed superficial veins. Edema of the extremity and deep calf tenderness are absent unless the deep veins are involved. Chills and high fever suggest septic or suppurative phlebitis, which is most often encountered as a complication of an indwelling intravenous catheter. Plastic intravenous catheters should be observed daily for signs of local inflammation and removed if a local reaction develops to avoid serious thrombotic or septic complications.
Differential Diagnosis
The linear rather than circular nature of the lesion and the distribution along the course of a superficial vein help to differentiate superficial phlebitis from cellulitis, erythema nodosum, erythema induratum, panniculitis, and fibrositis. Lymphangitis and deep thrombophlebitis must also be considered.
Treatment
The primary treatment of superficial venous thrombophlebitis is the administration of nonsteroidal anti-inflammatory drugs, local heat, and elevation. Ambulation is encouraged. In the majority of circumstances, symptoms will resolve within 7-10 days. Excision of the involved vein is recommended for symptoms that persist over 2 weeks on treatment, or for recurrent phlebitis in the same vein segment. If there is progressive proximal extension to the saphenofemoral junction or cephalic-subclavian junction, ligation and resection of the vein at the junction should be performed. Anticoagulation is reserved for rapidly progressing disease or extension into the deep system.
Septic thrombophlebitis requires treatment with intravenous antibiotics. As the causative organism is often staphylococcus or a gram-negative rod, broad-spectrum antibiotic coverage should be instituted until blood culture results become available. If rapid resolution of the phlebitis occurs, no treatment beyond a 7- to 10-day course of antibiotics is required. However, if the patient becomes septic, immediate excision of the infected vein is required.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Heart & Blood Vessels →
NewsEmerging vascular risk factors in women: Any differences from men?
The incidence and severity of both traditional and emerging cardiovascular disease (CVD) risk factors as well as the response to treatment may differ between genders. In this narrative review, several emerging CVD risk…
6 February 2016
NewsStudy shows minorities had lower risk of coronary heart disease than whites
In a study of more than 1.3 million Kaiser Permanente members in Northern California that stretched over 10 years, researchers found that blacks, Latinos and Asians generally had lower risk of coronary heart disease…
29 January 2016
NewsFinding the right antithrombotic (anti-clotting) drug for you
A new blood clotting analysis system designed in Japan makes it easier to determine the effects of taking one or more antithrombotic (anti-clotting) drugs. Myocardial infarction, arrhythmia (atrial fibrillation),…


.jpg)


